Abstract
Machine learning with maximization (support) of separating margin (vector), called support vector machine (SVM) learning, is a powerful classification tool that has been used for cancer genomic classification or subtyping. Today, as advancements in high-throughput technologies lead to production of large amounts of genomic and epigenomic data, the classification feature of SVMs is expanding its use in cancer genomics, leading to the discovery of new biomarkers, new drug targets, and a better understanding of cancer driver genes. Herein we reviewed the recent progress of SVMs in cancer genomic studies. We intend to comprehend the strength of the SVM learning and its future perspective in cancer genomic applications.
- Machine learning (ML)
- support vector machine (SVM)
- classifier
- genomics
- kernel function
- gene expression
- cancer classification
- gene selection
- biomarker discovery
- drug discovery
- driver gene
- gene-gene interaction
- review
- Received September 7, 2017.
- Revision received October 3, 2017.
- Accepted October 23, 2017.
- Copyright© 2018, International Institute of Anticancer Research (Dr. George J. Delinasios), All rights reserved
In this issue
Applications of Support Vector Machine (SVM) Learning in Cancer Genomics
Jump to section
Related Articles
Cited By...
- SOD2- and NRF2-associated Gene Signature to Predict Radioresistance in Head and Neck Cancer
- Combining Multi-Dimensional Molecular Fingerprints to Predict hERG Cardiotoxicity of Compounds
- Do Support Vector Machines play a role in stratifying patient population based on cancer biomarkers?
- PRPS-ST: A Protocol-Agnostic Self-training Method for Gene Expression-Based Classification of Blood Cancers
- Machine learning-based investigation of the cancer protein secretory pathway
- A mechanism-aware and multiomic machine-learning pipeline characterizes yeast cell growth
- Predicted Prognosis of Patients with Pancreatic Cancer by Machine Learning
- Fenchel duality of Cox partial likelihood and its application in survival kernel learning
- Robust gene expression-based classification of cancers without normalization
- Prediction of Tumor Grade and Nodal Status in Oropharyngeal and Oral Cavity Squamous-cell Carcinoma Using a Radiomic Approach
- Tumor Immune Microenvironment and Chemosensitivity Signature for Predicting Response to Chemotherapy in Gastric Cancer
- Software as a Service for the Genomic Prediction of Complex Diseases
- Uncertainty Reduction in Biochemical Kinetic Models: Enforcing Desired Model Properties
- Accurate ethnicity prediction from placental DNA methylation data